PFDDWORKS

Serial Number 88724531
602

Registration Progress

Application Filed
Dec 12, 2019
Under Examination
Dec 29, 2020
Approved for Publication
Nov 3, 2020
Published for Opposition
Nov 3, 2020
Registered

Trademark Image

PFDDWORKS

Basic Information

Serial Number
88724531
Filing Date
December 12, 2019
Published for Opposition
November 3, 2020
Abandonment Date
May 8, 2023
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
May 26, 2023
Classes
038

Rights Holder

Faegre Drinker Biddle & Reath LLP

21
Address
90 South Seventh Street
2200 Wells Fargo Center
Minneapolis, MN 55402

Ownership History

Faegre Baker Daniels LLP

Original Applicant
99
Minneapolis, MN

Faegre Baker Daniels LLP

Owner at Publication
99
Minneapolis, MN

Faegre Drinker Biddle & Reath LLP

New Owner After Publication #1
21
Minneapolis, MN

Legal Representation

Attorney
Stephanie A. Gumm

USPTO Deadlines

All Deadlines Cleared

All 11 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

44 events
Date Code Type Description Documents
May 30, 2023 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
May 26, 2023 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
May 26, 2023 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Nov 6, 2022 CNFR W SU - FINAL REFUSAL - WRITTEN Loading...
Nov 6, 2022 GNFR O FINAL REFUSAL E-MAILED Loading...
Nov 6, 2022 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Oct 29, 2022 ALIE A ASSIGNED TO LIE Loading...
Oct 29, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 29, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 16, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 17, 2022 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Mar 17, 2022 GNRT O NON-FINAL ACTION E-MAILED Loading...
Mar 17, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 10, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 1, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 28, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 27, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Dec 27, 2021 IUAF S USE AMENDMENT FILED Loading...
Jul 9, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 8, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 8, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 29, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 29, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 29, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 3, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 3, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 20, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 14, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 23, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 22, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 22, 2020 GNRT O NON-FINAL ACTION E-MAILED Loading...
Sep 22, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 22, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 22, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 22, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 26, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 26, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 26, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 12, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 12, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 12, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 12, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 16, 2019 NWAP I NEW APPLICATION ENTERED Loading...
Dec 16, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 038
Providing a collaboration platform in the nature of online forums in the field of disease advocacy for disease advocacy organizations and their stakeholders to share experiences, develop best practices, and promote sound policy solutions for patient-focused drug development
First Use Anywhere: Jan 6, 2020
First Use in Commerce: Jan 6, 2020

Classification

International Classes
038